0001493152-21-028917.txt : 20211116 0001493152-21-028917.hdr.sgml : 20211116 20211116150958 ACCESSION NUMBER: 0001493152-21-028917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211018 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beyer Russell P CENTRAL INDEX KEY: 0001889754 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 211415714 MAIL ADDRESS: STREET 1: 2100 E 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 W. 41ST STREET STREET 2: SUITE 202 CITY: MIAMI BEACH STATE: FL ZIP: 33140 BUSINESS PHONE: (305) 204-3338 MAIL ADDRESS: STREET 1: 300 W. 41ST STREET STREET 2: SUITE 202 CITY: MIAMI BEACH STATE: FL ZIP: 33140 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 ownership.xml X0306 4 2021-10-18 0 0001833214 SAB Biotherapeutics, Inc. SABS 0001889754 Beyer Russell P 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104 0 1 0 0 Chief Financial Officer Common Stock 2021-10-18 4 A 0 2475 10.10 A 2475 D Common Stock 2021-09-28 4 A 0 149 10.08 A 149 I By spouse Common Stock 2021-10-25 4 A 0 129 7.78 A 278 I By spouse Common Stock 2021-10-26 4 S 0 278 7.90 D 0 I By spouse Common Stock 2021-09-28 4 A 0 5 10.07 A 5 I By daughter Common Stock 2021-09-29 4 A 0 10 10.08 A 15 I By daughter This transaction occurred prior to the business combination pursuant to the Agreement and Plan of Merger, dated June 21, 2021 and as amended August 12, 2021, by and among Big Cypress Acquisition Corp., Big Cypress Merger Sub Inc., and SAB Biotherapeutics, Inc. ("Issuer"). The reporting person's obligation to disclose this transaction occurred upon the consummation of the business combination. The sale of Issuer common stock by the reporting person's spouse reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 278 shares, with the purchase of 278 shares of Issuer's common stock as also reported herein. The reporting person has paid to Issuer, upon settlement of the sale, $15.48, representing the full amount of the profit realized in connection with the short-swing transaction. /s/ Russell Beyer 2021-11-16